Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Serum levels of calcitonin in uremic patients in the predialytic phase and on regular dialytic treatment.

Di Landro D, Luisetto G, Tizian L, Pennetta C, Urso M, Romagnoli GF.

Contrib Nephrol. 1988;65:101-6. No abstract available.

PMID:
3168456
2.
3.

[Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].

Di Landro D, Zanatta GP, Simioni N, Pinzani A, Zotti D, Perin N, Bertoli M, Naso A, Ruffatti A, Gasparotto ML, et al.

Minerva Med. 1985 Mar 10;76(9-10):419-23. Italian. No abstract available.

PMID:
3982699
4.

Effects of 1-alpha OH D3 therapy in uremic patients in conservative or dialytic treatment.

Lamperi S, Vagge R.

Int J Artif Organs. 1979 Sep;2(5):243-7.

PMID:
478681
5.

[Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis].

Palmieri P, Albertazzi A, Cappelli P, Di Paolo B.

G Clin Med. 1981 Jul;62(7):443-60. Italian. No abstract available.

PMID:
7308629
6.

[Clinico-morphological correlations in uremic osteodystrophy of patients with conservative and hemodialytic treatment with special regard to the ultrastructure].

Bonucci E, Gherardi G, Mioni G, Castellani A, Cecchettin M, Cristinelli L, Migozzi G, Maiorca R, Maschio G, D'Angelo A, Ossi E, Lupo A, Valvo E.

Minerva Nefrol. 1975 Mar-Jun;22(2-3):99-108. Italian. No abstract available.

PMID:
1226257
7.

[Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].

Bucciante G, Bernardi A, Biasia F, Milan G, Donato D.

Minerva Med. 1985 Mar 10;76(9-10):415-7. Italian. No abstract available.

PMID:
3982698
8.

Photonic densitometry for the diagnosis of the uremic osteodystrophy.

Bordoni E, Baldelli S, Bibiano L, Bichi Secchi E, Lombardi M, Lombardo V, Micucci G, Procaccini G, Mioli V.

Life Support Syst. 1985;3 Suppl 1:503-6. No abstract available.

PMID:
3870615
9.

Effects of oral cimetidine on parathyroid hormone and calcitonin plasma levels in uremic patients.

Sebert JL, Decourcelles PH, Moriniere P, de Fremont JF, Gueris J, Makdassi R, Khassouf J, Andrejak M, Fournier A.

Adv Exp Med Biol. 1982;151:677-84. No abstract available.

PMID:
7180670
10.

[Use of "active" vitamin D in uremic osteodystrophy].

Tarchini R, Mioli V, Baldelli S, Figus S, Pacchiarotti P.

Minerva Med. 1982 Oct 20;73(40):2775-8. Italian. No abstract available.

PMID:
6290945
11.

Renal osteodystrophy in course of periodic dialysis for chronic uremia.

Kim D, Bell NH, Bundesen W, Putong P, Simon NM, Walker C, Del Greco F.

Trans Am Soc Artif Intern Organs. 1968;14:367-71. No abstract available.

PMID:
5701557
12.

Hormonal changes in uremia.

Bonomini V, Orsoni G, Stefoni S, Vangelista A.

Clin Nephrol. 1979 Jun;11(6):275-80. No abstract available.

PMID:
477043
13.

[Correlations between osteodensitometry and parameters of uremic osteodystrophy].

Sforzini S, Viganò MR, Beretta P, Rosa M, d'Amico P, Lomuscio G, Paesani R.

Minerva Med. 1985 Mar 10;76(9-10):445-8. Italian. No abstract available.

PMID:
3982703
15.

Strontium overload in uremic patients on regular dialytic treatment.

Canavese C, Pacitti A, Salomone M, Santoro MA, Stratta P, Mangiarotti G, Talarico S, Sabbioni E, Pietra R, Vercellone A.

ASAIO Trans. 1986 Jul-Sep;32(1):120-2. No abstract available.

PMID:
3778695
16.

Renal osteodystrophy: management of hyperphosphataemia.

Drüeke TB.

Nephrol Dial Transplant. 2000;15 Suppl 5:32-3. Review. No abstract available. Erratum in: Nephrol Dial Transplant 2001 Aug;16(8):1733.

PMID:
11073273
17.

Calcitonin secretion in chronic renal patients treated with hemodialysis.

Gozariu L, Manasia M, Paţiu IM, Vlăduţiu D, Barabas E, Spânu C, Căprioară M.

Endocrinologie. 1981 Oct-Dec;19(4):253-6.

PMID:
7323650
18.

[Use of Aloglutamol in uremic patients on dialysis (author's transl].

Bonanno A, Tonini GM, de Marinis S.

Urol Int. 1978;33(4):213-21. French.

PMID:
705977
19.

Plasma calcitonin in renal osteodystrophy.

Chittal SM, Oreopoulos DG, DeVeber GA, Thomas P, Rabinovich S, Lloyd GJ, Kumar MA, Rapoport A.

Can Med Assoc J. 1971 Jun 19;104(12):1098-100.

20.

[Differential effects of 1,25-hydroxycholecalciferol in uremic osteodystrophy].

Tarchini R, Pacchiarotti P, Figus S, Perilli A, Baldelli S, Mioli V.

Minerva Nefrol. 1981 Apr-Jun;28(2):147-50. Italian. No abstract available.

PMID:
6895244

Supplemental Content

Support Center